Eradivir

View 5 free companies with a free account

Get full access to valuations, team members, funding history, and investor details.

Investors

Venture capital firms, private equity investors, and strategic partners

Investor	Type
Biomedical Advanced Research and Development Authority	N/A
National Science Foundation Innovation Corps Program	N/A
Ollin Ventures	N/A
Park City Angels	N/A
Philip Low	N/A

+4 More Investors Available

Types of Investors

Eradivir has attracted various types of institutional and strategic investors

Common Investor Types

•Venture Capital Firms: Early-stage and growth equity investors
•Private Equity: Later-stage institutional investors
•Strategic Investors: Corporations in related industries
•Angel Investors: High-net-worth individuals
•Family Offices: Private wealth management firms

What Investors Provide

✓Capital for growth and expansion
✓Strategic guidance and expertise
✓Industry connections and partnerships
✓Market validation and credibility
✓Board representation and governance

Who Invested in Eradivir?

Eradivir has attracted investment from 9+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $30.1M in capital to fuel the company's growth.

Why Do Investors Fund Eradivir?

Investors are attracted to Eradivir due to the company's strong market position, growth potential, and proven business model. The company's current valuation of $113M reflects investor confidence in its ability to generate returns through continued growth, potential IPO, or strategic acquisition.

Types of Eradivir Investors

Eradivir investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.

Investor FAQs

How many investors does Eradivir have?

Eradivir has had 9+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.

Who are the lead investors in Eradivir?

Lead investors typically invest the largest amounts and often take board seats. For detailed information about Eradivir's lead investors and cap table structure, please contact our team.

Can I become an investor in Eradivir?

Accredited investors can purchase Eradivir shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.